News
The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.
In the Phase 2 study of patients with chronic kidney disease, the highest dose of the drug lowered by 86% the levels of ...
WASHINGTON — Robert F. Kennedy Jr. clinched the political support needed to become the nation’s top health official by ...
FDA Commissioner Marty Makary said his agency plans to release a new framework for vaccine approvals in “coming days.” ...
The upcoming changes raise questions about people who may still want a fall COVID-19 shot but don't clearly fall into one of the categories.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results